Fig. 01 -

C Ca & HPV Testing

Fig. 02 -

Disclosures

Fig. 03 -

Objectives

Fig. 04 -

Cervical Cancer

Fig. 05 -

Dysplasia (SIL) Progression

Fig. 06 -

Screening Evolution: Big Picture

Fig. 07 -

Screening Evolution: Pap Test

Fig. 08 -

CCS - The Pap Test

Fig. 09 -

CCS - Liquid Based Pap Test

Fig. 10 -

Pap Test Comparisons

Fig. 11 -

Pap Test Impact

Fig. 12 -

Screening Evolution: HPV Test

Fig. 13 -

HPV

Fig. 14 -

CCS: HPV Test

Fig. 15 -

HPV in Females

Fig. 16 -

HPV: Oncogenesis

Fig. 17 -

Cervical CA HPV Testing

Fig. 18 -

Qiagen: Hybrid Capture 2

Fig. 19 -

Hologic: Cervista

Fig. 20 -

Roche: cobas 4800

Fig. 21 -

Hologic: Aptima

Fig. 22 -

CCS Evolution: Clinical Guidelines

Fig. 23 -

CCS - Goals

Fig. 24 -

ALTS Study

Fig. 25 -

ALTS Study Results

Fig. 26 -

CCS Guidelines for Average-Risk

Fig. 27 -

Managing Abnormal CCS Results (1)

Fig. 28 -

Managing Abnormal CCS Results (2)

Fig. 29 -

Primary HPV Screening

Fig. 30 -

ATHENA Trial

Fig. 31 -

Interim Guidelines

Fig. 32 -

Primary HPV Screening Algorithm

Fig. 33 -

Cervical Screening Guidelines

Fig. 34 -

CCS & ACA

Fig. 35 -

Affordable Care Act

Fig. 36 -

ACA Preventive Services

Fig. 37 -

What about the vaccine?

Fig. 38 -

HPV Vaccine

Fig. 39 -

HPV Vaccination Barriers

Fig. 40 -

Our Experience

Fig. 41 -

Public Health Setting Guidelines

Fig. 42 -

Revisiting the Guidelines

Fig. 43 -

WI Women's Health

Fig. 44 -

HPV Prevalence In-House

Fig. 45 -

HPV Prevalence Send-Out (1)

Fig. 46 -

HPV Prevalence Send-Out (2)

Fig. 47 -

What Does It Mean?

Fig. 48 -

Population Difference?

Fig. 49 -

Take Home Thoughts

Fig. 50 -

Thank You!